Prioritization of Candidate Cancer Subtype Specific Drugs

A systematic biology tool was developed to prioritize cancer subtype-specific drugs by integrating genetic perturbation, drug action, biological pathway, and cancer subtype. The capabilities of this tool include inferring patient-specific subpathway activity profiles in the context of gene expression profiles with subtype labels, calculating differentially expressed subpathways based on cultured human cells treated with drugs in the 'cMap' (connectivity map) database, prioritizing cancer subtype specific drugs according to drug-disease reverse association score based on subpathway, and visualization of results (Castelo (2013) ; Han et al (2019) ; Lamb and Justin (2006) ). Please cite using .


Reference manual

It appears you don't have a PDF plugin for this browser. You can click here to download the reference manual.


0.1.5 by Junwei Han, 7 months ago

Report a bug at

Browse source code at

Authors: Xudong Han , Junwei Han , Chonghui Liu

Documentation:   PDF Manual  

GPL (>= 2) license

Imports BiocGenerics, GSVA, grDevices, graphics, igraph, parallel, pheatmap, rvest, stats, xml2, ChemmineR

Suggests knitr, rmarkdown

See at CRAN